πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Vera Therapeutics Patents

Full USPTO pharma patent portfolio for Vera Therapeutics β€” grant dates, expiration, and drug cross-links.

Patents
140
Expiring ≀24m
2

Quick answer

Vera Therapeutics has 140 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β€” use filters for patent-cliff planning.

Page 1 of 3

  1. US 12403164

    Lentiviral vector formulations

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12403183

    Factor VIII polypeptide formulations

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12391750

    Anti-C1S antibodies and methods of use thereof

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12371747

    Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12364774

    Nucleic acid molecules and uses thereof for non-viral gene therapy

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12268688

    Compositions and methods of use for modified release minoxidil

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12257288

    Methods of inducing immune tolerance to clotting factors

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12240917

    Anti-complement C1s antibodies and uses thereof

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12215169

    Anti-complement C1s antibodies and uses thereof

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12201639

    Aqueous oral pharmaceutical suspension compositions

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12186375

    Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12173307

    Methods for the purification of viral vectors

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12161696

    Methods of treating hemophilic arthropathy using chimeric clotting factors

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12128092

    Lyophilized factor IX formulations

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12059400

    Medical compound

    Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12030925

    Methods of treating hemophilia A

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12005220

    Microneedle patch for immunostimulatory drug delivery

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11976329

    Methods and systems for detecting usual interstitial pneumonia

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11877989

    Nutritional supplement containing L-Ξ±-glycerophosphorylcholine

    Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11873296

    Solid forms of a dual RAF/MEK inhibitor

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11833159

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11753461

    Optimized factor VIII genes

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11690853

    Non-hormonal steroid modulators of NF-ΞΊΞ² for treatment of disease

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11685771

    Recombinant factor VIII proteins

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11642398

    Factor IX polypeptide formulations

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11639527

    Methods for nucleic acid sequencing

    Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11564927

    Therapeutic compositions, combinations, and methods of use

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11471471

    Aqueous oral pharmaceutical suspension compositions

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11450420

    Secure smart dosing system with automated delivery, measurement, and management for pills

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11401322

    Immunoglobulin chimeric monomer-dimer hybrids

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11382922

    Aqueous oral pharmaceutical suspension compositions

    Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11370827

    Chimeric factor VIII polypeptides and uses thereof

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11372008

    Blood factor monitoring assay and uses thereof

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11298317

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11286528

    Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11266720

    Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11261437

    Procoagulant compounds

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11246926

    Polynucleotides encoding anti-C1s antibodies

    Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11229600

    Compositions and methods for selective GI tract delivery

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11225650

    Methods of using FIX polypeptides

    Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11192936

    Factor VIII chimeric proteins and uses thereof

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11192944

    Methods of inducing complement activity

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11168125

    Immunoglobulin chimeric monomer-dimer hybrids

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11168316

    Chimeric clotting factors

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11091534

    Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11083850

    Secure smart dosing system with automated delivery, measurement, and management

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10968442

    Chimeric clotting factors

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10947170

    Process for the preparation of deuterated ethanol from D2O

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Vera Therapeutics have?

140 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Vera Therapeutics patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.